Dudediligence.

Candel Therapeutics, Inc

CADLNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$10.6MSep ’24−$14.1MDec ’24$7.4MMar ’25−$4.8MJun ’25−$11.3MSep ’25−$29.5MDec ’25−$8.9MMar ’26−$38.9MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$125,000$125,000none on filenone on filenone on file
Operating income−$25.7M−$34.7M−$38.4M−$33.4M−$48.3M
Net income−$36.1M−$18.8M−$37.9M−$55.2M−$38.2M
Operating cash flow−$22.2M−$31.4M−$34.2M−$27.0M−$38.3M
Free cash flow−$24.1M−$32.7M−$34.7M−$27.0M−$38.9M
Cash$82.6M$70.1M$35.4M$102.7M$119.7M
Debt$560,000none on file$8.9M$9.9M$0.00
Shares outstanding28.7M28.9M29.1M46.8M54.9M